Skip to content
Cold-chain shipping · Ships from Canada · Research use only
Performance

SLU-PP-332 in Canada

SLU-PP-332 is a small lab-made molecule, not a peptide. Saint Louis University scientists first reported it in 2023. It switches on all three estrogen-related receptors, gene switches that run how cells use energy, especially in muscle. Its published evidence is from lab models and cells. No person has received it in a registered study, and it is not approved anywhere.

SLU-PP-332 peptide 5mg vial, Pro Peptide
$74.77CAD per vial

Pack prices and discount codes don't combine. You always get the bigger saving.

Strength5mg
1

In stock · ships same-day with ice pack

Sold for laboratory research use only. Not for human or veterinary use. 19+.

First characterised, Saint Louis University
2023
Molar mass: a small molecule, not a peptide
290.3g/mol
Estrogen-related receptors it switches on
3
Registered human studies
0
Approved as a drug
Nowhere

What is SLU-PP-332?

The plain-language version, first.

SLU-PP-332 is the newest chemistry on this shelf, built in a university lab to switch on receptors with no natural owner.

Housekeeping first, one final time: not a peptide. No amino acids, no bonds between them. A synthetic small molecule filed here by market habit.

Its targets are the strangest thing about it: the estrogen-related receptors, ERR alpha, beta and gamma, called orphan receptors because no natural hormone has ever been found that owns them.

Despite the name they do not bind estrogen. They run metabolic gene programmes, particularly in muscle, and they sit there switched by mechanisms biology has not fully explained.

SLU-PP-332, built at Saint Louis University in the 2020s, switches all three at once.

A master key for locks that never had an official key. That is genuinely novel, and novel cuts both ways.

What is SLU-PP-332?

What researchers watch it do.

Exercise-adjacent gene programmes, switched from a bench in St. Louis.

The ERRs regulate gene programmes associated with muscle energy metabolism, the same territory exercise adaptation works in.

Hence the inevitable nickname: exercise mimetic. In lab models, activating these receptors shifted muscle toward endurance-associated fibre programmes.

The nickname deserves suspicion on principle. Exercise is a whole-body event involving hundreds of systems, and a molecule touching one receptor family mimics a slice of it at most.

Pan-agonism raises its own flag: all three ERRs, in every tissue that expresses them, with tissue-selectivity nobody has mapped.

Here's the honest part, and it is shorter than usual.

First lab papers: 2023 and 2024. Human pharmacokinetics, safety, anything at all: zero. This is bench chemistry, present tense.

What does the research say about SLU-PP-332?

What the studies found, and where they stand.

Lab papers from the 2020s and nothing else. Genuinely nothing.

The complete published record fits in a sentence: lab studies from the mid-2020s showing endurance-associated changes, from the originating group and early collaborators.

No human has received this compound in any registered study. No safety data in people exists. The molecule is younger than some items in your fridge.

Independent replication: pending. Long-term animal data: pending. Everything: pending.

Nothing approved, obviously, and sport regulators have already flagged the exercise-mimetic class in principle.

The frontier, sold as a product. Whatever this molecule turns out to be, nobody knows it yet, including everyone currently selling it.

Have a look at current stock and vial sizes.

What did the lab find in our SLU-PP-332?

The lab's numbers for the lot on the shelf.

99.36%HPLC purity
Lot 2236-696
LaboratoryJanoshik Analytical
TestedAugust 2026
MethodHPLC + mass spectrometry
Size5 mg, freeze-dried powder
Stored atKeep it cold and out of the light
Reported resultsas reported by the laboratory
HPLC purity
99.36%
Identity
Confirmed
Measured content
label 5 mg4.89 mg

See the lab results page

What's in a vial of SLU-PP-332?

The chemistry, exactly as released.

Identity
Molecular formulaC18H14N2O2
CAS number303760-60-3
Molar mass290.3 g/mol
Handling
FormatFreeze-dried powder
StorageKeep it cold and out of the light
ReconstitutionBacteriostatic water
Work out the drawPeptide calculatorLab resultsLot 2236-696

Who studies SLU-PP-332?

Who tends to order this one, and why.

  1. 1

    Nuclear receptor pharmacology

    Orphan receptors with no established natural ligand are among the harder targets to drug, and this scaffold is a notable success at it.

  2. 2

    Muscle and mitochondrial biology

    Fibre type composition, mitochondrial biogenesis and the PGC-1 alpha partnership that runs the endurance adaptation programme.

  3. 3

    Cardiology

    The 2024 Circulation paper attributed cardiac benefit in a lab pressure-overload model to ERR gamma rather than alpha, suggesting tissue-specific roles.

  4. 4

    Anti-doping laboratories

    Two groups published in vitro metabolite maps and detection methods in 2026, both explicitly framing the compound as having doping potential.

Sold for laboratory research only. This is not guidance for personal use, and nothing here is a recommendation.

Where did SLU-PP-332 come from?

How it got here.

The exercise mimetic idea has a long and mostly disappointing history. The appeal is obvious and the difficulty is that exercise does many things at once through many pathways, so single-target compounds capture a fraction of it.

The nuclear receptor route is one of the more rational attempts. If endurance adaptation is a transcriptional programme, and specific receptors run that programme, then agonising those receptors is a defined intervention with a measurable readout rather than a vague claim.

The estrogen-related receptors were a natural target once ERR alpha and PGC-1 alpha were understood as partners in mitochondrial biogenesis. The obstacle for years was chemistry: orphan receptors with no known natural ligand are hard to make agonists for.

Thomas Burris and colleagues at Saint Louis University solved that part. Burris is now at the University of Florida Genetics Institute, and the medicinal chemistry programme around this scaffold has continued.

  1. 1

    A long-standing idea

    Exercise mimetics have an appealing premise and a difficult history, because exercise acts through many pathways at once and single-target compounds capture a fraction.

  2. 2

    The transcriptional route

    Endurance adaptation is a gene expression programme. ERR alpha partnered with PGC-1 alpha is one of its central drivers, which makes it a defined target with a measurable readout.

  3. 3

    Saint Louis University, 2023

    The Burris laboratory solved the chemistry problem of building an agonist for an orphan receptor and published the first characterisation in ACS Chemical Biology.

How do I buy SLU-PP-332 in Canada?

What ships, how fast, and the paperwork.

This is a small molecule, not a peptide. Molecular weight 290, no amino acids, no peptide bonds. It sits in a peptide catalogue for commercial reasons rather than chemical ones, and handling and reconstitution behave differently from a peptide.

Same day out of British Columbia. Our building, our cold packs, our people, and nothing sitting in a customs queue while you refresh a tracking page.

Prohibited under S0. It is not named on the WADA 2026 list, but section S0 captures any pharmacological substance with no current approval by any governmental regulatory health authority. SLU-PP-332 has no approval anywhere, so S0 applies and it is prohibited at all times. Two laboratories published detection methods for it in 2026.

What else do people ask?

5 answers, none of them dodges.

Is SLU-PP-332 a peptide?

No. It is a small-molecule acylhydrazone with a molecular weight of 290.3 and no amino acids or peptide bonds in it. For comparison, the peptides in this catalogue generally run between 700 and 5,000 daltons. Anyone describing it as a peptide is describing the wrong class of molecule.

Has any human taken SLU-PP-332?

Not in any published or registered study. ClinicalTrials.gov returns zero studies for it. PubMed returns ten records, all preclinical, medicinal chemistry, review or doping-control analytical work. There is no human pharmacokinetic or safety data of any kind.

What about the study with 20 women in it?

That one is frequently misread. Bonanni and colleagues in Frontiers in Physiology in 2025 enrolled 20 women undergoing hip replacement and collected muscle biopsies. SLU-PP-332 was then applied to primary myoblast cultures grown from that tissue in the laboratory. No participant received the compound. It is human tissue in a dish, not a human study.

What are estrogen-related receptors?

Orphan nuclear receptors named for their sequence similarity to the estrogen receptor. Despite the name they do not bind estrogen and are not part of estrogen signalling. ERR alpha partners with the coactivator PGC-1 alpha to drive mitochondrial biogenesis and oxidative metabolism, which is the transcriptional programme endurance training engages.

How strong is the lab evidence?

Good, by preclinical standards. Three papers: increased oxidative muscle fibres and running endurance with the effect abolished in ERR alpha null animals, increased energy expenditure and reduced fat mass in obese models, and improved cardiac function and survival in a heart failure model. The knockout control in the first paper is the important part, because it demonstrates the compound works through the claimed target rather than something else.

What pairs well with SLU-PP-332?

What researchers stack alongside it.

Pairing is where research gets ahead of itself. These are the compounds researchers put in the same order as SLU-PP-332, which is a statement about ordering habits, not about evidence. Two things in one cart have not been studied together unless somebody studied them together.

LongevityMOTS-c Peptide

Your cells' batteries text head office when fuel runs low, and this is the text. Lab research has looked at it for fuel use and endurance.

1
In stock · ships same-day with ice pack
LongevitySS-31 Peptide (Elamipretide)

A four-building-block lab-made protein that heads straight for your mitochondria, the power plants in your cells. It parks on the fat that holds their machinery in place, like a regular on his favourite barstool, and the FDA approved it in 2025 for a rare disease where those power plants fail.

1
In stock · ships same-day with ice pack

Supplies for the lab

SuppliesBacteriostatic Water

The water every freeze-dried vial needs, and the one item everybody forgets. Sterile water with a preservative, so one vial lasts more than one draw.

1
In stock · ships same-day with ice pack

What else is in Performance?

Other compounds in the same research category.

See all 24 in Performance →

Ready to order SLU-PP-332?

One last look before you decide.

Freeze-dried, lab results on the page, ships cold

You've got the file and the lab's numbers that back it, lot by lot. If that's the kind of source you were after, SLU-PP-332 is right here.

For research use only

Sold for laboratory research use only. Not for human or veterinary use, and not for human consumption. 19+. Not approved by Health Canada or any other regulatory body.

Page last updated November 12, 2026. Reviewed by the Pro Peptide team.

What do people search for with SLU-PP-332?

Related searches.